SCHEMBL13636195

SCHEMBL13636195

O=C(CCc1ccc(O)c(O)c1)N1CCN(c2ccncc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.54
ME2 P23368 2/20 0.53
ME1 P48163 2/20 0.53
ME3 Q16798 2/20 0.53
MAPT P10636 3/20 0.49
KMT2A Q03164 2/20 0.49
GFER P55789 1/20 0.49
MEN1 O00255 1/20 0.49
CHRM1 P11229 1/20 0.48
F10 P00742 1/20 0.47
ITGB3 P05106 4/20 0.46
ITGA2B P08514 4/20 0.46
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GRM5 P41594 1/20 0.46
MMP2 P08253 1/20 0.45
LMNA P02545 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4375437 0.81 KMT2A (0.72) KMT2AGFERMEN1ALDH1A1SMN1; SMN2
SCHEMBL4379381 0.81 TRPV1 (0.57) MAPTKMT2AGFERMEN1CHRM1
SCHEMBL4375445 0.80 HRH3 (0.60) ME2ME1ME3MAPTKMT2A
SCHEMBL9345400 0.80 NPC1 (0.61) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL13636226 0.79 ME2 (0.50) ROCK2ME2ME1ME3MAPT
SCHEMBL4375389 0.79 FKBP1A (0.65) ME2ME1ME3MAPTKMT2A
SCHEMBL9336419 0.79 FKBP1A (0.64) KMT2AALDH1A1NPSR1
SCHEMBL9346536 0.79 IAPP (0.53) ROCK2MAPTKMT2ASMN1; SMN2
SCHEMBL4380598 0.79 ME2 (0.57) ME2ME1ME3MAPTKMT2A
SCHEMBL9350110 0.78 NPC1 (0.59) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed